Oral immunization with a recombinant Lactococcus lactis-expressing HIV-1 antigen on group A streptococcus pilus induces strong mucosal immunity in the gut

Journal of Immunology

Volumn 195, Issue 10, 2015, Pages 5025-5034

  Chamcha, Venkateswarlu ^a   Jones, Andrew ^a   Quigley, Bernard R ^b   Scott, June R ^b   Amara, Rama Rao ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VECTOR; CPA PROTEIN; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MODIFIED VACCINIA VIRUS ANKARA 5T4 VACCINE; PROBIOTIC AGENT; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BACTERIUM PILUS; BLOOD; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; FECES; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; INTESTINE; INTESTINE EPITHELIUM CELL; LACTOCOCCUS LACTIS; LAMINA PROPRIA; MESENTERY LYMPH NODE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; SERUM; SMALL INTESTINE; STREPTOCOCCUS PYOGENES; VAGINAL SECRETION; ANIMAL; BAGG ALBINO MOUSE; FEMALE; FIMBRIA; GENETICS; IMMUNOLOGY; PATHOLOGY;

ANIMALS; BACTERIAL PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FIMBRIAE, BACTERIAL; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV ANTIBODIES; HIV-1; IMMUNITY, MUCOSAL; IMMUNIZATION; LACTOCOCCUS LACTIS; MICE; MICE, INBRED BALB C; PEYER'S PATCHES; RECOMBINANT FUSION PROTEINS; STREPTOCOCCUS PYOGENES;

EID: 84958683500     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501243     Document Type: Article

References (49)

1. Hladik, F., and M. J. McElrath. 2008. Setting the stage: host invasion by HIV. Nat. Rev. Immunol. 8: 447-457.
2. Letvin, N. L. 2006. Progress and obstacles in the development of an AIDS vaccine. Nat. Rev. Immunol. 6: 930-939.
3. Holmgren, J., and C. Czerkinsky. 2005. Mucosal immunity and vaccines. Nat. Med. 11(4, Suppl)S45-S53.
4. Belyakov, I. M., and J. A. Berzofsky. 2004. Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines. Immunity 20: 247-253.
5. Demberg, T., and M. Robert-Guroff. 2009. Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design. Int. Rev. Immunol. 28: 20-48.
6. Zhou, Q., R. Hidajat, B. Peng, D. Venzon, M. K. Aldrich, E. Richardson, E. M. Lee, V. S. Kalyanaraman, G. Grimes, V. R. Gómez-Román, et al. 2007. Comparative evaluation of oral and intranasal priming with replicationcompetent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIV(mac251). Vaccine 25: 8021-8035.
7. Veazey, R. S., M. DeMaria, L. V. Chalifoux, D. E. Shvetz, D. R. Pauley, H. L. Knight, M. Rosenzweig, R. P. Johnson, R. C. Desrosiers, and A. A. Lackner. 1998. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280: 427-431.
8. Smit-McBride, Z., J. J. Mattapallil, M. McChesney, D. Ferrick, and S. Dandekar. 1998. Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes. J. Virol. 72: 6646-6656.
9. Mattapallil, J. J., D. C. Douek, B. Hill, Y. Nishimura, M. Martin, and M. Roederer. 2005. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
10. Bahey-El-Din, M. 2012. Lactococcus lactis-based vaccines from laboratory bench to human use: an overview. Vaccine 30: 685-690.
11. Xin, K. Q., Y. Hoshino, Y. Toda, S. Igimi, Y. Kojima, N. Jounai, K. Ohba, A. Kushiro, M. Kiwaki, K. Hamajima, et al. 2003. Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env. Blood 102: 223-228.
12. Klijn, N., A. H. Weerkamp, and W. M. de Vos. 1995. Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl. Environ. Microbiol. 61: 2771-2774.
13. Sáez, D., P. Fernández, A. Rivera, E. Andrews, and A. Oñate. 2012. Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity. Vaccine 30: 1283-1290.
14. Kunji, E. R. S., D.-J. Slotboom, and B. Poolman. 2003. Lactococcus lactis as host for overproduction of functional membrane proteins. Biochim. Biophys. Acta 1610: 97-108.
15. Quigley, B. R., M. Hatkoff, D. G. Thanassi, M. Ouattara, Z. Eichenbaum, and J. R. Scott. 2010. A foreign protein incorporated on the Tip of T3 pili in Lactococcus lactis elicits systemic and mucosal immunity. Infect. Immun. 78: 1294-1303.
16. Gram, G. J., A. Fomsgaard, M. Thorn, S. M. Madsen, and J. Glenting. 2007. Immunological analysis of a Lactococcus lactis-based DNA vaccine expressing HIV gp120. Genet. Vaccines Ther. 5: 3.
17. Pusch, O., R. Kalyanaraman, L. D. Tucker, J. M. Wells, B. Ramratnam, and D. Boden. 2006. An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli. AIDS 20: 1917-1922.
18. Pontes, D. S., M. S. de Azevedo, J. M. Chatel, P. Langella, V. Azevedo, and A. Miyoshi. 2011. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems. Protein Expr. Purif. 79: 165-175.
19. Guimarães, V. D., S. Innocentin, F. Lefèvre, V. Azevedo, J. M. Wal, P. Langella, and J. M. Chatel. 2006. Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells. Appl. Environ. Microbiol. 72: 7091-7097.
20. Raha, A. R., N. R. Varma, K. Yusoff, E. Ross, and H. L. Foo. 2005. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine. Appl. Microbiol. Biotechnol. 68: 75-81.
21. Amara, R. R., F. Villinger, J. D. Altman, S. L. Lydy, S. P. O'Neil, S. I. Staprans, D. C. Montefiori, Y. Xu, J. G. Herndon, L. S. Wyatt, et al. 2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292: 69-74.
22. Kwa, S., L. Lai, S. Gangadhara, M. Siddiqui, V. B. Pillai, C. Labranche, T. Yu, B. Moss, D. C. Montefiori, H. L. Robinson, et al. 2014. CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge. J. Virol. 88: 9579-9589.
23. Kwa, S., S. Sadagopal, X. Shen, J. J. Hong, S. Gangadhara, R. Basu, B. Victor, S. S. Iyer, C. C. LaBranche, D. C. Montefiori, et al. 2015. CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection. J. Virol. 89: 4690-4695.
24. Smith, J. M., R. R. Amara, D. Campbell, Y. Xu, M. Patel, S. Sharma, S. T. Butera, D. L. Ellenberger, H. Yi, L. Chennareddi, et al. 2004. DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime. AIDS Res. Hum. Retroviruses 20: 1335-1347.
25. Holo, H., and I. F. Nes. 1989. High-Frequency Transformation, by Electroporation, of Lactococcus lactis subsp. cremoris Grown with Glycine in Osmotically Stabilized Media. Appl. Environ. Microbiol. 55: 3119-3123.
26. Biswas, I., P. Germon, K. McDade, and J. R. Scott. 2001. Generation and surface localization of intact M protein in Streptococcus pyogenes are dependent on sagA. Infect. Immun. 69: 7029-7038.
27. Liu, J., M. Hellerstein, M. McDonnel, R. R. Amara, L. S. Wyatt, B. Moss, and H. L. Robinson. 2007. Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost. Vaccine 25: 2951-2958.
28. Ganguly, S., J. Liu, V. B. Pillai, R. S. Mittler, and R. R. Amara. 2010. Adjuvantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: different effects on cellular and humoral immunity. Vaccine 28: 1300-1309.
29. Denning, T. L., Y. C. Wang, S. R. Patel, I. R. Williams, and B. Pulendran. 2007. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 8: 1086-1094.
30. Kozlowski, P. A., S. Cu-Uvin, M. R. Neutra, and T. P. Flanigan. 1997. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect. Immun. 65: 1387-1394.
31. Quigley, B. R., D. Zähner, M. Hatkoff, D. G. Thanassi, and J. R. Scott. 2009. Linkage of T3 and Cpa pilins in the Streptococcus pyogenes M3 pilus. Mol. Microbiol. 72: 1379-1394.
32. O'Connell, R. J., J. H. Kim, L. Corey, and N. L. Michael. 2012. Human immunodeficiency virus vaccine trials. Cold Spring Harb. Perspect. Med. 2: a007351.
33. Munseri, P. J., A. Kroidl, C. Nilsson, A. Joachim, C. Geldmacher, P. Mann, C. Moshiro, S. Aboud, E. Lyamuya, L. Maboko, et al. 2015. Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial. PLoS One 10: e0119629.
34. Nimmerjahn, F., and J. V. Ravetch. 2005. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310: 1510-1512.
35. Yates, N. L., H. X. Liao, Y. Fong, A. deCamp, N. A. Vandergrift,W. T. Williams, S. M. Alam, G. Ferrari, Z. Y. Yang, K. E. Seaton, et al. 2014. Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination. Sci. Transl. Med. 6: 228ra39.
36. Iwasaki, A. 2007. Mucosal dendritic cells. Annu. Rev. Immunol. 25: 381-418.
37. Coombes, J. L., and F. Powrie. 2008. Dendritic cells in intestinal immune regulation. Nat. Rev. Immunol. 8: 435-446.
38. Mascola, J. R., and D. C. Montefiori. 2010. The role of antibodies in HIV vaccines. Annu. Rev. Immunol. 28: 413-444.
39. Ryan, E. J., L. M. Daly, and K. H. Mills. 2001. Immunomodulators and delivery systems for vaccination by mucosal routes. Trends Biotechnol. 19: 293-304.
40. Yates, N. L., J. T. Lucas, T. L. Nolen, N. A. Vandergrift, K. A. Soderberg, K. E. Seaton, T. N. Denny, B. F. Haynes, M. S. Cohen, and G. D. Tomaras. 2011. Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection. AIDS 25: 2089-2097.
41. Iwasaki, A., and B. L. Kelsall. 2001. Unique functions of CD11b+, CD8 a+, and double-negative Peyer's patch dendritic cells. J. Immunol. 166: 4884-4890.
42. Scott, C. L., A. M. Aumeunier, and A. M. Mowat. 2011. Intestinal CD103+ dendritic cells: master regulators of tolerance? Trends Immunol. 32: 412-419.
43. Mowat, A. M. 2003. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3: 331-341.
44. Spalding, D. M., S. I. Williamson, W. J. Koopman, and J. R. McGhee. 1984. Preferential induction of polyclonal IgA secretion by murine Peyer's patch dendritic cell-T cell mixtures. J. Exp. Med. 160: 941-946.
45. Spalding, D. M., and J. A. Griffin. 1986. Different pathways of differentiation of pre-B cell lines are induced by dendritic cells and T cells from different lymphoid tissues. Cell 44: 507-515.
46. Sato, A., M. Hashiguchi, E. Toda, A. Iwasaki, S. Hachimura, and S. Kaminogawa. 2003. CD11b+ Peyer's patch dendritic cells secrete IL-6 and induce IgA secretion from naive B cells. J. Immunol. 171: 3684-3690.
47. Coffman, R. L., D. A. Lebman, and B. Shrader. 1989. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharidestimulated murine B lymphocytes. J. Exp. Med. 170: 1039-1044.
48. Sonoda, E., R. Matsumoto, Y. Hitoshi, T. Ishii, M. Sugimoto, S. Araki, A. Tominaga, N. Yamaguchi, and K. Takatsu. 1989. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 170: 1415-1420.
49. Klijn, N., A. H. Weerkamp, and W. M. de Vos. 1995. Detection and characterization of lactose-utilizing Lactococcus spp. in natural ecosystems. Appl. Environ. Microbiol. 61: 788-792.